Claybrook Capital’s Johnson & Johnson JNJ Stock Holding History

Claybrook Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,834	Closed	-$300K	–	137
2022 Q3	$300K	Hold	1,834	–	–	0.19%	99
2022 Q2	$326K	Hold	1,834	–	–	0.19%	100
2022 Q1	$325K	Hold	1,834	–	–	0.16%	107
2021 Q4	$314K	Buy	1,834 +154	+9%	+$25.2K	0.15%	114
2021 Q3	$271K	Sell	1,680 -43,825	-96%	-$7.48M	0.14%	115
2021 Q2	$7.5M	Buy	45,505 +43,825	+2,609%	+$7.26M	2.44%	6
2021 Q1	$276K	Hold	1,680	–	–	0.16%	101
2020 Q4	$264K	Hold	1,680	–	–	0.17%	80
2020 Q3	$250K	Hold	1,680	–	–	0.19%	75
2020 Q2	$236K	Hold	1,680	–	–	0.2%	71
2020 Q1	$220K	Hold	1,680	–	–	0.2%	73
2019 Q4	$259K	Hold	1,680	–	–	0.12%	98
2019 Q3	$217K	Hold	1,680	–	–	0.11%	96
2019 Q2	$234K	Hold	1,680	–	–	0.12%	92
2019 Q1	$235K	Sell	1,680 -9,323	-85%	-$1.25M	0.12%	89
2018 Q4	$1.42M	Buy	11,003 +9,323	+555%	+$1.3M	0.4%	46
2018 Q3	$232K	Hold	1,680	–	–	0.14%	77
2018 Q2	$204K	Hold	1,680	–	–	0.13%	77
2018 Q1	$215K	Hold	1,680	–	–	0.14%	75
2017 Q4	$235K	Buy	+1,680	New	+$234K	0.17%	79

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Claybrook Capital's JNJ Position: Q4 2022 in Review

Claybrook Capital sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 1,834 shares — an estimated $300K sold.

Claybrook Capital first reported a position in JNJ in Q4 2017 and held it in 20 quarters. The position peaked at $7.5M in Q2 2021. 3,789 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

Claybrook Capital reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
Claybrook Capital sold 1,834 Johnson & Johnson shares in Q4 2022, an estimated $300K.
Claybrook Capital first reported a position in Johnson & Johnson in Q4 2017 and held it in 20 quarters.
Claybrook Capital's Johnson & Johnson position peaked at $7.5M in Q2 2021.
3,789 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Claybrook Capital's 13F filing for Q4 2022, filed 24 Jan 2023.